LANSING, Mich., Jan. 28, 2013 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company" or "Kraig") announced today that World Textile Information Network ("WTiN") recently published an article, entitled "Commercializing the science of spider silk", featuring the Company and its genetically engineered spider silk technologies.
As the WTiN article states, "Kraig Biocraft Laboratories has experienced growing success developing its recombinant spider silk in the last two years." The article describes Kraig's product development and includes the first published photos of the Company's new composite spider silk fiber, "Big Red." The new genetically engineered spider silk fiber takes its name from the fact that it glows bright red under UV illumination. Additional photos of what the Company hopes to be a breakthrough material will be posted on Kraig's website.
The WTiN article is available at the following link: http://ei.wtin.com/article/fQowSDlzdX2/2013/01/24/commercialising_the_science_of_spider_silk/.
World Textile Information Network, established more than 100 years ago and based in the UK, is the world's leading textile news and information provider, with unrivalled textile expertise. "WTiN Intelligence" is part of the WTiN, whose magazines include- Textile Month International, Knitting International, Future Materials, Nonwovens Report International, Digital Textile, Twist and International Dyer, as well as newspapers at many of the world's leading textile exhibitions.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com) is a fully reporting biotechnology company that has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 email@example.comSource:Kraig Biocraft Laboratories, Inc